Results 31 to 40 of about 45,533 (284)

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction

open access: yesFrontiers in Neuroscience
We describe the clinical presentation, pathophysiology, and successful treatment of a previously undocumented adult onset, progressive form of monoamine oxidase A hypofunction.
Stefan Berteau, Erik Armitano
doaj   +1 more source

Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase’s and monoamine oxidases: Novel target for the treatment of Alzheimer disease [PDF]

open access: yesJournal of the Serbian Chemical Society
Molecular docking is a promising and reliable technology for the purpose of discovering lead compounds via virtual screening. In addition to allowing for the testing of a large number of compounds, it also allows for the determination of how the selected
Ejaz Syeda Abida   +4 more
doaj   +1 more source

Computation-based experimentation: Identification of piperazine containing antidepressants

open access: yesPakistan Journal of Pharmaceutical Sciences, 2021
Depression, a common mental disorder, is one of the major contributors to the overall global burden with more than 264 million individuals affected worldwide. Monoamine oxidase inhibitors (MAOIs) have well-known efficacy for treating depression and other
Saman Usmani   +6 more
doaj   +1 more source

Monoamine Oxidase and Behaviour

open access: yesAnnals of Medicine, 1995
Item does not contain ...
openaire   +3 more sources

Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides [PDF]

open access: yes, 2009
Based on a recent report that 1-methyl-3-phenylpyrrolyl analogues are moderately potent reversible inhibitors of the enzyme monoamine oxidase B (MAO-B), a series of structurally related N-methyl-2-phenylmaleimidyl analogues has been prepared and ...
Petzer, Jacobus P.   +4 more
core   +1 more source

Crystallization of Human Monoamine Oxidase B [PDF]

open access: yes, 2023
: The interest in monoamine oxidases A and B (MAO A and B) is due to their central role in regulating the balance of neurotransmitters, both in the central nervous system and in peripheral organs.
Mattevi, Andrea   +2 more
core   +1 more source

Synthesis of the flavocoenzyme of monoamine oxidase [PDF]

open access: yesFEBS Letters, 1971
Reaction scheme is entirely in accord with our own conclusion that the go-substituent in the case of MAO-flavin must be a functional group devoid of acid-base properties, though capable of donating electrons to and accepting excitons from the flavin nucleus.
Ghisla, Sandro, Hemmerich, Peter
openaire   +3 more sources

Inhibition of monoamine oxidase by E-styrylisatin analogues [PDF]

open access: yes, 2009
Previous studies have shown that (E)-8-(3-chlorostyryl)caffeine (CSC) is a specific reversible inhibitor of human monoamine oxidase B (MAO-B) and does not bind to human MAO-A.
Petzer, Jacobus P.   +4 more
core   +1 more source

Targeting monoamine oxidases for the treatment of betel quid dependence: a potential pharmacological and neurobiological approach

open access: yesFrontiers in Pharmacology
The trend of betel quid chewing has witnessed a gradual upsurge in recent years, indicating increased dependence on betel quid/betel-nut and complications of withdrawal. Dedicated efforts towards the development of effective cessation strategies are thus
Sorbomita Chakraborty   +3 more
doaj   +1 more source

Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B [PDF]

open access: yes, 2010
The parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its corresponding five-membered ring analogue 1-methyl-3-phenyl-3-pyrroline are cyclic tertiary allylamines and good substrates of monoamine oxidase B (MAO-B).
Petzer, Jacobus P.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy